Literature DB >> 8477745

Vigilin is a cytoplasmic protein. A study on its expression in primary cells and in established cell lines of different species.

G Neu-Yilik1, H Zorbas, T R Gloe, H M Raabe, T A Hopp-Christensen, P K Müller.   

Abstract

A fusion protein composed of about two vigilin domains and beta-galactosidase was used to raise polyclonal antibodies which were affinity-purified and employed for immunoblotting and immunohistochemistry. A protein of an apparent molecular mass of 155 kDa could be stained in extracts of a variety of cells from different species and organs. Immunohistological studies on single cells showed that vigilin is accumulated in the cytoplasm. During in vitro maintenance of primary cell cultures, as well as of a growth-factor-dependent cell line, vigilin expression decreases and ceases in senescent cells. In contrast, vigilin is constitutively expressed in all other transformed cell lines of various origin studies so far. Vigilin expression can be induced in peripheral blood lymphocytes by mitogen stimulation. These observations suggest an involvement of vigilin in processes of cell activation. Immunoblot experiments demonstrating the presence of vigilin in a broad range of eukaryotes, indicate a high degree of evolutionary conservation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477745     DOI: 10.1111/j.1432-1033.1993.tb17813.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  8 in total

1.  In vitro genetic analysis of the RNA binding site of vigilin, a multi-KH-domain protein.

Authors:  H Kanamori; R E Dodson; D J Shapiro
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

2.  The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation.

Authors:  L Wiebusch; C Hagemeier
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

3.  Chicken vigilin gene: a distinctive pattern of hypersensitive sites is characteristic for its transcriptional activity.

Authors:  A Grünweller; W G Purschke; S Kügler; C Kruse; P K Müller
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Evidence for a novel cytoplasmic tRNA-protein complex containing the KH-multidomain protein vigilin.

Authors:  C Kruse; A Grünweller; H Notbohm; S Kügler; W G Purschke; P K Müller
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

5.  The human vigilin gene: identification, chromosomal localization and expression pattern.

Authors:  G Plenz; S Kügler; S Schnittger; H Rieder; C Fonatsch; P K Müller
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

6.  RNAi-mediated depletion of the 15 KH domain protein, vigilin, induces death of dividing and non-dividing human cells but does not initially inhibit protein synthesis.

Authors:  Kathryn M Goolsby; David J Shapiro
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

7.  The N-terminus of FILIA forms an atypical KH domain with a unique extension involved in interaction with RNA.

Authors:  Juke Wang; Mengyuan Xu; Kai Zhu; Lei Li; Xinqi Liu
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

8.  HDLBP binds ER-targeted mRNAs by multivalent interactions to promote protein synthesis of transmembrane and secreted proteins.

Authors:  Ulrike Zinnall; Miha Milek; Igor Minia; Carlos H Vieira-Vieira; Simon Müller; Guido Mastrobuoni; Orsalia-Georgia Hazapis; Simone Del Giudice; David Schwefel; Nadine Bley; Franka Voigt; Jeffrey A Chao; Stefan Kempa; Stefan Hüttelmaier; Matthias Selbach; Markus Landthaler
Journal:  Nat Commun       Date:  2022-05-18       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.